Home / 2021 / May / 11

Daily Archives: May 11, 2021

Wasabi Enhances Cloud-Based Data Security with S3 Object Lock Support

Powerful new feature secures data with the ultimate protection against ransomware, malicious or accidental alteration and deletion

Boston, MA, May 11, 2021 (GLOBE NEWSWIRE) — Wasabi, the hot cloud storage company, today announces S3 Object Lock, a new feature that allows users to store immutable objects in Wasabi’s cloud using applications that support S3 object locking like Veeam® Backup & Replication™. Wasabi’s support for S3 Object Lock introduces a new level of data protection, preventing malicious or accidental operations that can lead to significant data loss or alteration. The feature further enhances Wasabi’s commitment to data security, including 11x9s of data durability, strong identity & multi-factor authentication, and compliance with the latest privacy and security standards.

Whether accidental or malicious, preventing catastrophic data loss is increasingly challenging, especially when defending against ransomware attacks, mitigating the impact of human error or ensuring the chain of custody and regulatory compliance of data. With S3 Object Lock, applications or storage administrators can designate certain data objects as immutable, meaning the content cannot be altered or deleted by any application or user, including ransomware attacks. Immutability is set for a specific period of time, allowing businesses to more simply meet governance compliance requirements.

“Providing seamless, timely, and secure data backup and replication is key to any company’s long-term cloud storage strategy,” said Andreas Neufert, Vice President of Product Management, Alliances at Veeam. “Our partnership with Wasabi has allowed us to provide this capability to our joint customers for years. With the addition of S3 Object Lock, Wasabi has earned Veeam Ready Object with Immutability qualification which ensures our joint customers have the highest level of protection for their cloud storage needs. This aligns with our ‘3-2-1-1-0’ rule for ultimate data protection: Maintain at least 3 copies of your data on 2 different media with at least 1 copy at an off-site location and 1 copy offline or immutable, and ensure verified backups with 0 errors.”

Object Lock is offered free of charge, included with Wasabi’s flexible, predictable and industry-leading pricing model. This provides users with the freedom to test business continuity and conduct the day-to-day monitoring and management required of critical data protection practices. Wasabi with Object Lock is verified as “Veeam Ready — Object with Immutability” with Veeam Backup & Replication v10 and v11 and meets the regulatory requirements for data immutability and retention management supported by Veeam.

“Data immutability is a critical, but often challenging step, in the data protection process. The addition of S3 Object Lock makes it easier than ever for customers to ensure their data is protected from any threat and enables them to cost-effectively validate their data protection strategy,” said David Boland, Senior Director of Product Marketing at Wasabi. “Wasabi’s support for S3 Object Lock is just the latest offering to help companies improve their cloud storage strategies without breaking the bank.”

To learn more about Wasabi Object Lock, visit our website.

About Wasabi:

Wasabi provides simple, predictable and affordable hot cloud storage for businesses all over the world. It enables organizations to store and instantly access an infinite amount of data at 1/5th the price of the competition with no complex tiers or unpredictable egress fees. Trusted by tens of thousands of customers worldwide, Wasabi has been recognized as one of technology’s fastest-growing and most visionary companies. Created by Carbonite co-founders and cloud storage pioneers David Friend and Jeff Flowers, Wasabi has secured nearly $250 million in funding to date and is a privately held company based in Boston.

Follow and connect with Wasabi on Twitter, Facebook, Instagram and our blog.

Nick Brown
InkHouse for Wasabi
wasabi@inkhouse.com

Acuant Strengthens Anti-Money Laundering and Cryptocurrency Compliance Solutions with Blockchain Analysis Leader Chainalysis

The Power of Acuant + Chainalysis

Acuant + Chainalysis combine to provide best-in-class AML software.

LOS ANGELES, May 11, 2021 (GLOBE NEWSWIRE) — Acuant, the global trusted identity platform for fraud prevention and AML compliance, today announced its partnership with Chainalysis, the blockchain analysis company, to help financial institutions and cryptocurrency businesses assess risk, automate workflows, safeguard against illicit transactions and protect their reputations with superior Anti-Money Laundering (AML) solutions.

Acuant and Chainalysis customers will now be able to leverage both platforms via the Acuant interface to seamlessly manage transactions that are indicative of higher risk. They will have access to Chainalysis Know Your Transactions (KYT) as well as their graphical investigative software, Chainalysis Reactor, which can be used to follow the flow of funds across the blockchain for deeper investigations. Th​e integration of Reactor and KYT strengthens Acuant Compliance native cryptocurrency support with Chainalysis investigative interface.​

“We at Chainalysis believe cryptocurrency has the potential to boost the global economy, making a more equitable, fair and accessible financial infrastructure. In order to realize this vision, we need to establish greater trust and transparency,” said Jordan Bregman, Director of Business Development at Chainalysis. “Our partnership with Acuant brings us closer to this goal and we’re excited to see our progress within the next few years.”

Acuant Compliance currently provides comprehensive AML solutions to more than 50 crypto exchanges and blockchain businesses worldwide. Its native support for cryptocurrencies along with integrated Know Your Customer (KYC), transaction monitoring for fraud prevention and suspicious activity detection, sanctions and PEP screening, case management and multijurisdictional regulatory filing protects millions of cryptocurrency transactions worldwide.

“Our partnership with Chainalysis will further augment our support to the cryptocurrency industry. This partnership is bringing together and integrating the top Anti-Money Laundering solutions in the marketplace today,” said Jose Caldera, Chief Product Officer at Acuant. “We look forward to working with Chainalysis to strengthen our platform and to continue to be a leading solutions provider in the crypto space.”

Chainalysis KYT helps financial institutions and cryptocurrency businesses monitor large volumes of cryptocurrency activity and identify high-risk transactions on a continuous basis. The Chainalysis KYT and Acuant integration combines a comprehensive dataset of thousands of services with solutions that make it easy to review both fiat and cryptocurrency transactions, detect suspicious activity, manage investigations, and file suspicious activity reports (SARs). Real time alerts on the highest-risk activity allow compliance teams to focus on the most urgent activity and fulfill regulatory obligations to report suspicious transactions.

About Acuant
Acuant’s Trusted Identity Platform is at the forefront of enabling businesses and governments to transact with trust in an ever-increasing digital world, facilitating the creation, ownership and ability to verify your identity and making that accessible to the entire global population. With industry leading identity verification, regulatory compliance (AML/KYC) and digital identity solutions powered by AI and human assisted machine learning, Acuant delivers unparalleled results and operational efficiency. Omnichannel deployment delivers seamless customer experiences to fight fraud, increase conversions and establish trust in seconds from anywhere in the world. Completing more than 1.5 billion transactions in over 200 countries and territories, Acuant powers trust in every major industry.

About Chainalysis
Chainalysis is the blockchain analysis company. We provide data, software, services, and research to government agencies, exchanges, financial institutions, and insurance and cybersecurity companies in over 60 countries. Our data platform powers investigation, compliance, and risk management tools that have been used to solve some of the world’s most high-profile cybercriminal cases and grow consumer access to cryptocurrency safely. Backed by Accel, Addition, Benchmark, Ribbit, and other leading names in venture capital, Chainalysis builds trust in blockchains to promote more financial freedom with less risk.

Media Contact
Malini Gujral
marketing@acuant.com

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0cc2f7d8-9bc3-4ddb-9e1e-a5e9523abc4b

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dc47955d-c7d2-48ba-9961-a9e437c3572e

Ocean Network Express (ONE) Launches Digital Freight Booking Platform Powered by Descartes Kontainers

WATERLOO, Ontario, May 11, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Singapore-based Ocean Network Express (ONE), the world’s sixth largest container carrier, is using the Descartes Kontainers solution to digitize the shipper-facing aspects of its freight execution operations in 11 Asian countries as part of a pilot program.

“Shippers today need a more efficient and streamlined end-to-end freight booking experience,” Hiroki Tsujii, Managing Director, Marketing & Commercial said at ONE. “With the launch of our new digital platform ONE QUOTE, powered by Descartes Kontainers, customers can now receive an instant quote for export shipments and place bookings anytime, anywhere. It’s a one stop service that completely automates traditional manual tasks.”

The Descartes Kontainers solution facilitates a fully digital customer experience including quoting, booking, tracking and dashboard analytics for shipping lines, freight forwarders, ocean transportation intermediaries (OTI) and non-vessel operating common carriers (NVOCC) around the world. The digital freight execution platform enables these logistics services providers (LSP) to rapidly create branded, online self-service experiences for their customers. With its recent acquisition of Portrix Logistics Systems, Descartes can also now provide freight forwarders with a comprehensive digital solution for engaging customers and managing rates. However, the solution also helps LSPs preserve investments in existing rate management and back-office systems and quickly get their digital customer experience live through the use of standardized APIs. Even large carriers and LSPs such as ONE are able to get customers booking freight in just a few months.

“We are pleased to help ONE simplify and enhance the customer experience through digitization,” said Graham Parker, VP Digital Freight Solutions at Descartes. “As the shift to digitize customer-facing operations accelerates, it is increasingly valuable to have a leading execution platform that can provide rates, quotes, and the ability to book cargo and track it on demand on any Internet-enabled device.”

For more details on ONE QUOTE, see the video here.

About Ocean Network Express Pte. Ltd.

Headquartered in Singapore, Ocean Network Express (ONE) was founded in 2017 as a new entity from three Japanese liner companies – ‘K’​ Line, MOL and NYK – who historically prided themselves on high level service quality and process excellence. These characteristics, which we highly cherish, are also the founding core principles of ONE. With a global fleet of over 250 vessels, active participation in all major global trade lanes, deployment of the latest IT systems and an extensive terminal ownership portfolio.

About Descartes

Descartes (Nasdaq:DSGX) (TSX:DSG) is the global leader in providing on-demand, software-as-a-service solutions focused on improving the productivity, performance and security of logistics-intensive businesses. Customers use our modular, software-as-a-service solutions to route, schedule, track and measure delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; access global trade data; file customs and security documents for imports and exports; and complete numerous other logistics processes by participating in the world’s largest, collaborative multimodal logistics community. Our headquarters are in Waterloo, Ontario, Canada and we have offices and partners around the world. Learn more at www.descartes.com, and connect with us on LinkedIn and Twitter.

Global Media Contact
Cara Strohack
Tel: +1(800) 419-8495 ext. 202025
cstrohack@descartes.com

Cautionary Statement Regarding Forward-Looking Statements

This release contains forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that relate to Descartes’ solution offering and potential benefits derived therefrom; the speed in which customers may be able to achieve benefits from the solution and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, “Certain Factors That May Affect Future Results” in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada including Descartes most recently filed management’s discussion and analysis. If any such risks actually occur, they could materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

TeraRecon Appoints Sinan Batman CTO

CTO to advance Enterprise Imaging Decision Support and EurekaAI Enterprise Platform

DURHAM, N.C., May 11, 2021 (GLOBE NEWSWIRE) — Advanced visualization and AI leader TeraRecon today announced the appointment of Sinan Batman as Chief Technology Officer, responsible for developing next-gen, AI-based advanced visualization and clinical workflow application technologies.

“Sinan shares our drive for better patient outcomes and value through out-of-the-box solutions for streamlined efficiency and effectiveness,” said Romesh Wadhwani, chairman and founder of parent company SymphonyAI. “He brings a track record of delivering value to customers by building and deploying innovative solutions that make analytics and decision support simple, ubiquitous, and transparent.”

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems. At Fujifilm Medical Systems USA, he was Executive Technical Director of Research and Development, heading the core medical IT product development and leading 200 product releases. Batman directed the Digital Innovation and Data Science Teams at Hillrom, leading the development of class-leading health risk prediction algorithms across the care continuum.

Earlier In his career, Batman has developed computer-aided diagnosis algorithms for breast cancer detection and was one of the early scientists working on quantifying gene expression using microarray imaging technologies for the US National Institutes of Health. He developed advanced autonomous medical imaging algorithms for disease and target detection as a research scientist at Johns Hopkins University. Batman modeled, simulated, and optimized quantum-well laser diodes and arrays while working as a Research Scientist at Xerox Research Labs in a NASA-sponsored project.

“Time-to-value is an essential ingredient for product and technology success,” said Batman. “It takes more than sophisticated tools, like a high-quality AI platform, though that is a necessity. Success comes from the hard work of developing real solutions that business enterprises can see value from immediately. Solutions must use a nuanced understanding of how healthcare works. TeraRecon understands that and is leading the enterprise AI movement in healthcare as a result.”

About TeraRecon: TeraRecon is a leader in medical advanced visualization with a mission to continuously redefine patient and healthcare by strategically leveraging AI innovation. The flagship Intuition product is the 2021 KLAS category leader for advanced visualization and holds the number one market share for US 3D imaging. A SymphonyAI business since 2020, TeraRecon is continuing to innovate ahead of customer demand with sophisticated healthcare-focused AI platform solutions unlike any in the world today.

For more information, visit www.terarecon.com or email marketing at info@terarecon.com.

US Approves Pfizer COVID-19 Vaccine for Children as Young as 12

U.S. regulators have authorized the COVID-19 vaccine developed by Pfizer-BioNTech to be used by children as young as 12 years of age, widening the pool of those eligible to get inoculated.

The U.S. Food and Drug Administration said Monday the shot is safe and effective for children ages 12 to 15. The vaccine is already available under an emergency use authorization to those 16 and older.

“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” Acting FDA Commissioner Janet Woodcock said in a statement.

The Pfizer vaccine is the first in the United States to be approved for younger people. The approval comes as U.S. officials are seeking to inoculate a larger percentage of the population and will likely prompt millions of U.S. middle and high school students to try to be vaccinated before they head back to class in the fall.

While most children with COVID-19 only develop mild symptoms or have no symptoms at all, they are still able to pass along the virus to others.

In March, Pfizer released preliminary results from a vaccine trial involving more than 2,000 volunteers ages 12 to 15. The trial showed that none of the fully vaccinated adolescents came down with COVID-19 or experienced serious side effects.

In a related development on the vaccine front, introduction of another potential COVID-19 vaccine will be delayed until later this year. U.S.-based pharmaceutical company Novavax announced Monday it will not seek regulatory approval of its experimental vaccine until this July, citing problems in securing the raw materials and equipment needed to manufacture the vaccine.

But Novavax Chief Executive Stanley Erck told reporters on a conference call that the company expects to meet its goal of producing 150 million doses per month by the fourth quarter of this year.

Company officials said it expects to release the results of a late-stage clinical trial in North America sometime this month. A clinical trial conducted in Britain showed the vaccine is about 95-percent effective against the coronavirus.

Novavax has promised to supply more than 1 billion doses of the vaccine to the COVAX global vaccine sharing initiative for poor and middle-income nations, as well as 200 million shots to several European countries.

India

In other developments Monday, the World Health Organization said that a variant of the coronavirus circulating in India is of global concern.

“We classify it as a variant of concern at a global level,” Maria Van Kerkhove, WHO technical lead on COVID-19, told a briefing on the B.1.617 variant. “There is some available information to suggest increased transmissibility.”

The Philippines announced Tuesday that it had detected its first two cases of the Indian B.1.617 variant. The variant was discovered in two travelers who returned to the Philippines in April from Oman and the United Arab Emirates.

India’s daily COVID-19 statistics are down slightly but remain high. The Health Ministry reported 329,942 new infections in the previous 24-hour period Tuesday, including 3,876 deaths. Public health experts say they believe the new cases and deaths are undercounted.

India now has a total of 22.9 million COVID-19 infections and 249,992 deaths, according to the Johns Hopkins Coronavirus Resource Center. Only the U.S. has more infections, accounting for 32.7 million of the world’s 158.5 million cases, the center reported.

There is growing concern in India about a fungal infection affecting COVID-19 patients and people who have recovered from the disease. Mucormycosis is caused by mold and can affect a person’s facial structure. In some cases, it causes blindness. COVID-19 patients with diabetes are particularly susceptible to mucormycosis, medical experts said.

Source: Voice of America

Nepal Struggles With 2nd COVID Wave as India’s Outbreak Spills Across Border

MUMBAI, INDIA – Thousands of Nepalese migrants working in India rushed home in recent weeks seeking safe haven from a brutal second wave of the coronavirus pandemic as it battered the country with sickness and death.

Now, the small Himalayan country is confronting a crisis like India’s as its health care system buckles under an exponential rise in infections. Nepalese officials are calling for international assistance as it grapples with shortages of oxygen that have plagued India. Political turmoil after Nepali Prime Minister K.P. Sharma Oli lost a vote of confidence on Monday could make it harder to cope with the pandemic, analysts said.

“A number of people are dying as they search for hospitals or during their treatment,” Samir Kumar Adhikari, a spokesperson for Nepal’s Ministry of Health and Population, told VOA. “Almost all hospitals are packed, and although some have space, we are unable to operationalize them because of shortage of oxygen and other logistics.”

India and Nepal have an open border policy allowing free movement between the two countries — thousands of Nepalis travel for work in Indian cities, while Indians often travel to Nepal for business.

Officials say COVID-19 infections first started to rise in towns like Nepalganj along the Indian border. But Kathmandu Valley where the large cities are situated is now the epicenter of the second wave. Thousands of people have left the capital Kathmandu to return to their villages, raising fears that they will carry the infection and spread it into remote rural areas.

Nepal reported over 9,000 daily infections on Monday — 60 times what the country reported at the start of April when Nepal was counting around 150 daily infections.

A number of border crossings with India have been shut down in recent days. Most international flights have been halted and much of the country is under a lockdown order. Worried residents are lining up for inoculations, but until last month, only about 7% of the population had received one vaccine dose.

“It is a very pathetic situation in Nepal,” Nepal’s Red Cross Chairman, Netra Prasad Timsina told VOA. He says the country urgently needs international assistance to prevent the situation from worsening because the government’s resources are not enough to cope with the pandemic. “Nepal needs all the medical equipment for COVID-19 treatment — oxygen cylinders, concentrators and medicines.”

In a statement last week, Timsina said the situation in India was a “horrifying preview of Nepal’s future if we cannot contain this latest COVID surge.”

Nepal’s health care system is fragile — it has 1,595 intensive care beds and 480 ventilators for its about 30 million people, according to the government.

Political instability is adding to its woes, observers add. On Monday, Prime Minister Oli lost a vote of confidence in parliament paving the way for opposition parties to cobble a new ruling coalition.

Oli had been criticized for playing down the risk of the pandemic and asking citizens to treat the virus with hot water, guava leaves and turmeric powder.

Like in neighboring India, the government is also being blamed for letting down its guard when infections were low — the country was up and running, restaurants and markets were open, crowds gathered to celebrate festivals and Nepal reopened Mount Everest to foreign climbers. Masses political gatherings were held in recent months.

The government failed to prepare adequately for a second wave during the months when there was a lull in infections or for more transmissible variants that would spread more rapidly, public health experts said.

“We should have learned from [the United Kingdom] and Brazil how difficult it would be to contain the rapidly spreading variants and the measures needed to overcome the situation,” said Suresh Panthee of the Sustainable Study and Research Institute in Kathmandu. “Most importantly, once India started to see a rapid increase in cases, Nepal should have been vigilant to test, quarantine, and isolate. We should have seen the coming danger, but we did not.” He says the large political gatherings held in the country in recent months were “inexcusable.”

The virus appears to have traveled to the country’s most famous mountain — a Norwegian climber, Erlend Ness, said last month he had tested positive for COVID-19 at Everest Base camp. Nepalese culture and tourism ministry has however said that there are no health safety risks at the base camp.

The country’s former king, Gyanendra Bir Bikram Shah, and his queen, have been hospitalized after testing positive for COVID-19 following a trip to India in April where he attended the Kumbh mela, a Hindu religious festival that epidemiologists have flagged as a super spreader event.

Residents said they fear the spread of the virus in cities like Kathmandu after following the coverage of how people struggled in India’s hospitals.

“We see ambulances parked outside hospitals, people are not getting a bed,” says Vivek Sherchan, a Kathmandu resident who has tested positive for COVID-19. “We worry that the situation is about to get dire.”

Officials say that most of the infected people are at home without effective surveillance and warn that the country will not be able to cater to them if they need hospital care. The army is expanding health care facilities in border areas with India.

China is sending oxygen cylinders. But Nepal is yet to receive the large-scale international medical aid similar to India. India received assistance from over 40 countries.

“We immediately need international support. Right now, we need oxygen support,” said Adhikari, the country’s health ministry spokesperson. “The ministry of health is unable to address the real situation, real problem in hospitals, real problem in home isolation.”

Officials fear that conditions will only worsen in the coming days if the current trend continues. “We are struggling. The situation is getting out of control,” Adhikari said.

Source: Voice of America